We provide you with 20 years of free, institutional-grade data for IBM stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of IBM. Explore the full financial landscape of IBM stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$338,102
Name | Action | Shares | Avg Price | Amount | Reported Date |
---|---|---|---|---|---|
Fehring Nicolas A. | Sale | -1,388 | $243.59 | $338,103 | 2025-09-02 |
Fehring Nicolas A. | Derivatives Exercise | 2,742 | 2025-09-02 | ||
Robinson Anne | Sale | -5,662 | $292.6 | $1,656,673 | 2025-07-02 |
Robinson Anne | Derivatives Exercise | 10,237 | 2025-07-02 | ||
Fehring Nicolas A. | Sale | -262 | $268.85 | $70,439 | 2025-06-09 |
Fehring Nicolas A. | Derivatives Exercise | 517 | 2025-06-09 | ||
KRISHNA ARVIND | Sale | -4,298 | $268.85 | $1,155,517 | 2025-06-09 |
KRISHNA ARVIND | Derivatives Exercise | 8,606 | 2025-06-09 | ||
Thomas Robert David | Sale | -1,739 | $268.85 | $467,530 | 2025-06-09 |
Thomas Robert David | Derivatives Exercise | 3,443 | 2025-06-09 | ||
LAMOREAUX NICKLE JACLYN | Sale | -705 | $268.85 | $189,539 | 2025-06-09 |
LAMOREAUX NICKLE JACLYN | Derivatives Exercise | 1,379 | 2025-06-09 | ||
KAVANAUGH JAMES J | Sale | -2,588 | $268.85 | $695,784 | 2025-06-09 |
KAVANAUGH JAMES J | Derivatives Exercise | 5,163 | 2025-06-09 | ||
Thomas Robert David | Sale | -26,543 | $253.01 | $6,715,639 | 2025-03-03 |
FARR DAVID N | Open Market Purchase | 1,200 | $249 | 2025-02-28 | |
Fehring Nicolas A. | Sale | -559 | $262.93 | $146,975 | 2025-02-25 |
Fehring Nicolas A. | Derivatives Exercise | 1,566 | 2025-02-25 | ||
COHN GARY D | Sale | -4,193 | $262.93 | $1,102,445 | 2025-02-25 |
COHN GARY D | Derivatives Exercise | 7,579 | 2025-02-25 | ||
KAVANAUGH JAMES J | Sale | -4,928 | $262.93 | $1,295,694 | 2025-02-25 |
KAVANAUGH JAMES J | Derivatives Exercise | 9,832 | 2025-02-25 | ||
Thomas Robert David | Sale | -4,251 | $262.93 | $1,117,694 | 2025-02-25 |
Thomas Robert David | Derivatives Exercise | 8,410 | 2025-02-25 | ||
KRISHNA ARVIND | Sale | -8,466 | $262.93 | $2,225,923 | 2025-02-25 |
KRISHNA ARVIND | Derivatives Exercise | 16,899 | 2025-02-25 | ||
LAMOREAUX NICKLE JACLYN | Sale | -2,242 | $262.93 | $589,478 | 2025-02-25 |
LAMOREAUX NICKLE JACLYN | Derivatives Exercise | 4,389 | 2025-02-25 | ||
Thomas Robert David | Sale | -7,423 | $253.71 | $1,883,252 | 2025-02-12 |
Thomas Robert David | Derivatives Exercise | 14,714 | 2025-02-12 | ||
Thomas Robert David | Sale | -14,244 | $254.56 | $3,625,881 | 2025-02-03 |
Thomas Robert David | Grant, award...etc | 29,337 | 2025-02-03 | ||
Robinson Anne | Sale | -1,100 | $254.56 | $280,011 | 2025-02-03 |
Robinson Anne | Grant, award...etc | 2,679 | 2025-02-03 | ||
LAMOREAUX NICKLE JACLYN | Sale | -12,942 | $254.56 | $3,294,451 | 2025-02-03 |
LAMOREAUX NICKLE JACLYN | Grant, award...etc | 26,418 | 2025-02-03 | ||
KAVANAUGH JAMES J | Sale | -18,336 | $254.56 | $4,667,520 | 2025-02-03 |
KAVANAUGH JAMES J | Grant, award...etc | 37,719 | 2025-02-03 | ||
KRISHNA ARVIND | Sale | -28,249 | $254.56 | $7,190,924 | 2025-02-03 |
KRISHNA ARVIND | Grant, award...etc | 57,626 | 2025-02-03 | ||
Fehring Nicolas A. | Sale | -906 | $254.56 | $230,627 | 2025-02-03 |
Fehring Nicolas A. | Grant, award...etc | 2,445 | 2025-02-03 | ||
COHN GARY D | Sale | -16,803 | $254.56 | $4,277,288 | 2025-02-03 |
COHN GARY D | Grant, award...etc | 30,385 | 2025-02-03 | ||
COHN GARY D | Sale | -2,197 | $222.07 | $487,899 | 2025-01-06 |
COHN GARY D | Derivatives Exercise | 5,114 | 2025-01-06 | ||
ZOLLAR ALFRED W | Open Market Purchase | 936 | $210.62 | 2024-11-13 | |
LAMOREAUX NICKLE JACLYN | Sale | -3,600 | $215.2 | $774,727 | 2024-11-08 |
Fehring Nicolas A. | Sale | -1,388 | $200.47 | $278,259 | 2024-09-03 |
Fehring Nicolas A. | Derivatives Exercise | 2,742 | 2024-09-03 | ||
LAMOREAUX NICKLE JACLYN | Sale | -978 | $200.47 | $196,065 | 2024-09-03 |
LAMOREAUX NICKLE JACLYN | Derivatives Exercise | 1,915 | 2024-09-03 | ||
BROWDY MICHELLE H | Sale | -3,169 | $169.71 | $537,811 | 2024-06-11 |
BROWDY MICHELLE H | Derivatives Exercise | 6,203 | 2024-06-11 | ||
Fehring Nicolas A. | Sale | -466 | $169.71 | $79,085 | 2024-06-11 |
Fehring Nicolas A. | Derivatives Exercise | 1,041 | 2024-06-11 | ||
Thomas Robert David | Sale | -3,588 | $169.71 | $608,919 | 2024-06-11 |
Thomas Robert David | Derivatives Exercise | 7,115 | 2024-06-11 | ||
LAMOREAUX NICKLE JACLYN | Sale | -973 | $169.71 | $165,128 | 2024-06-11 |
LAMOREAUX NICKLE JACLYN | Derivatives Exercise | 1,903 | 2024-06-11 | ||
KAVANAUGH JAMES J | Sale | -5,439 | $169.71 | $923,053 | 2024-06-11 |
KAVANAUGH JAMES J | Derivatives Exercise | 10,851 | 2024-06-11 | ||
KRISHNA ARVIND | Sale | -9,316 | $169.71 | $1,581,018 | 2024-06-11 |
KRISHNA ARVIND | Derivatives Exercise | 18,695 | 2024-06-11 |
The information provided in this report about IBM stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
IBM(NYSE:IBM)


International Business Machines Corporation provides integrated solutions and services worldwide. Its Cloud & Cognitive Software segment offers software for vertical and domain-specific solutions in health, financial services, supply chain, and asset management, weather, and security software and se...
Website: http://www.ibm.com
Founded: 1911
Full Time Employees: 352,600
CEO: Arvind Krishna
Sector: Technology
Industry: Information Technology Services